Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Reunion Neuroscience Inc T.REUN

Healthcare Biotechnology
Reunion Neuroscience Inc. is engaged in the psychedelic drug development company that provides therapeutic solutions for mental health conditions by developing serotonin receptor agonist compounds. The Company is developing the advancement of synthetic molecules targeting serotonin 5HT2A receptors. The Company’s products include RE104 and RE200. The Company’s lead asset, RE-104, which is a... see more

Recent & Breaking News (TSX:REUN)

IIROC Trading Halt - FTRP

Canada NewsWire April 28, 2022

Field Trip Health Ltd. to Participate in Upcoming Investor Conferences

GlobeNewswire April 18, 2022

Field Trip Health (TSX:FTRP) granted US patent covering novel psychedelic molecule FT-104

Azuka Onwuka April 5, 2022

Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104

GlobeNewswire April 5, 2022

Field Trip Health Ltd. to Participate in Maxim Group 2nd Annual Virtual Growth Conference

GlobeNewswire March 23, 2022

Field Trip Health Ltd. to Participate in 34th Annual Roth Conference in March 2022

GlobeNewswire March 9, 2022

Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care

PR Newswire March 3, 2022

Field Trip Health (TSX:FTRP) announces 50 per cent revenue uptick in Q3

Akanksha Kumar February 16, 2022

Field Trip Health Ltd. Reports Third Fiscal Quarter 2022 Financial Results and Provides Business Update

GlobeNewswire February 15, 2022

Field Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results Conference Call for February 16, 2022 at 8:30 AM ET

GlobeNewswire February 1, 2022

Field Trip Health Ltd. to Participate in Citi's Psychedelic Drug Video Call Series

GlobeNewswire January 18, 2022

IIROC Trade Resumption - FTRP

PR Newswire January 11, 2022

Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development

GlobeNewswire January 11, 2022

IIROC Trading Halt - FTRP

PR Newswire January 11, 2022

Field Trip (TSX:FTRP) helps Canadians access psilocybin-assisted and MDMA-assisted therapy

Brieanna McCutcheon  January 6, 2022

Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada's Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted Therapies

GlobeNewswire January 6, 2022

Field Trip Health Ltd. to Participate in H.C. Wainwright Bioconnect Virtual Conference in January 2022

GlobeNewswire January 5, 2022

Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté as Head of Quality

GlobeNewswire December 14, 2021

Field Trip Health Ltd. to Participate in Upcoming Conferences in December 2021

GlobeNewswire December 1, 2021

Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update

GlobeNewswire November 15, 2021